Enhabit and Kinderhook: A Strategic Alignment

Barb Jacobsmeyer, President and CEO of Enhabit, expressed optimism about the transaction, stating that it represents a positive outcome for all stakeholders – stockholders, clinicians, caregivers, patients, and their families. She emphasized that Kinderhook’s ownership will provide Enhabit with the resources and expertise needed to invest in its workforce, enhance clinical quality, and drive innovation, free from the pressures of short-term public market expectations.

The terms of the agreement offer Enhabit stockholders $13.80 per share in cash, a premium of approximately 24.4% over the company’s closing stock price on February 20th, and a 33.8% premium to the 60-day volume-weighted average share price as of the same date. Jeffrey Bolton, Chairman of Enhabit’s Board of Directors, affirmed the board’s confidence that the transaction maximizes stockholder value after a thorough evaluation of the company’s position and future prospects.

Kinderhook Industries, a middle-market private equity firm with over $10 billion in committed capital, has a strong track record of investing in healthcare, environmental services, and industrial sectors. The firm specifically targets businesses with a “defensible niche market positioning,” suggesting Enhabit’s established presence and specialized services were key factors in the acquisition. Kinderhook’s existing healthcare portfolio includes Better Health Group, Avita Care Solutions, and AbsoluteCare, demonstrating their commitment to the evolving healthcare landscape.

Matt Bubis, Managing Director at Kinderhook, highlighted Enhabit’s reputation for excellence and the firm’s intention to support the company’s continued growth. “Our role is to grow and foster the great work they’re already doing and to help remove barriers so their teams can stay focused on patients,” Bubis stated. This suggests a hands-on, supportive approach to ownership, prioritizing patient care and operational efficiency.

Enhabit currently operates 249 home health locations and 117 hospice locations across 34 states, serving a broad geographic area. Importantly, the company plans to retain its name and brand identity following the completion of the acquisition, signaling a commitment to maintaining continuity for patients and partners.

Did You Know?: The home healthcare market is projected to experience substantial growth in the coming years, driven by demographic shifts and advancements in medical technology.

This deal unfolds during a period of leadership transition for Enhabit, as CEO Barb Jacobsmeyer previously announced her intention to step down in July 2026, or upon the appointment of her successor. The timing of the acquisition suggests a smooth transition is anticipated under Kinderhook’s ownership.

What impact will increased private equity investment have on the accessibility and affordability of home healthcare services? And how will Enhabit leverage Kinderhook’s resources to address the evolving needs of the aging population?

Further solidifying the trend of consolidation in the home health sector, this acquisition follows similar moves by other private equity firms, indicating a strong belief in the long-term potential of this market. Becker’s Hospital Review provides further insights into this growing trend.

The increasing demand for home-based care is also fueled by value-based care models, which incentivize providers to deliver cost-effective and high-quality care in the most appropriate setting. America’s Health Insurance Plans offers resources on the benefits of value-based care.

Frequently Asked Questions About the Enhabit Acquisition